Peak nasal inspiratory flow in chronic obstructive pulmonary disease
Rhinology Journal · 01.03.2023 · 0-0
DOI: 10.4193/rhin22.316 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rhinology Journal, online erschienen am 01.03.2023. Verfasst von W M Thorstensen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Head and Neck Surgery, St. Olavs University hospital, Trondheim, Norway; Department of Neuromedicine and Movement Scien…. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Nasal Polyps, Sinusitis. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Themen: COPD
Abstract (Originalsprache)
Background
The nasal airflow in chronic obstructive pulmonary disease (COPD) is poorly characterized. Peak nasal inspiratory flow (PNIF) is a valuable instrument for assessing nasal airflow and the effect of pulmonary pathology such as COPD on PNIF remains unknown. To test the hypothesis that nasal airflow is reduced in COPD, we assessed airflow using PNIF in COPD and a control group. We also explored whether there is an association between COPD, chronic rhinosinusitis without nasal polyps (CRSsNP), and other predefined covariates with PNIF. Methodology: Ninety patients with COPD and 67 controls underwent PNIF and spirometry. The associations between PNIF and COPD and pre-bronchodilator forced expiratory volume in the first second (FEV1) (% predicted) were assessed by multivariable linear regression in two separate models.
Results
PNIF was significantly lower in the COPD group than in the control group. Multivariable linear regression showed that COPD and pre-bronchodilator FEV1 (% predicted) were significantly associated with lower PNIF after adjustment for age, sex, CRSsNP, weight and height. CRSsNP was not associated with PNIF in either of the adjusted regression analyses.
Conclusions
PNIF is lower in COPD than in a control group. The finding of a low PNIF in the absence of disease in the upper airways may be due to obstructive lower airways diseases and special care should be taken when interpreting PNIF values in patients with COPD or reduced FEV1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology, Head and Neck Surgery, St. Olavs University hospital, Trondheim, Norway; Department of Neuromedicine and Movement Science, Norwegian University of Science and Technology (NTNU), Trondheim,…
- Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway; Department of Thoracic Medicine, St. Olavs University hospital, Trondheim, Norway.
- Department of Otolaryngology, Head and Neck Surgery, Sorlandet Hospital, Kristiansand, Norway; Haukeland University Hospital, Bergen, Norway.
- Department of Otolaryngology, Head and Neck Surgery, St. Olavs University hospital, Trondheim, Norway; Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway.
Zitieren
APA
Thorstensen, W. M., Rystad Oie, M., Sue-Chu, M., Karmhus Steinsvag, S., & Helvik, A. S. (2023). Peak nasal inspiratory flow in chronic obstructive pulmonary disease. Rhinology Journal, 0(0), 0-0. https://doi.org/10.4193/rhin22.316
Vancouver
Thorstensen WM, Rystad Oie M, Sue-Chu M, Karmhus Steinsvag S, Helvik AS. Peak nasal inspiratory flow in chronic obstructive pulmonary disease. Rhinology Journal. 2023;0(0):0-0. doi:10.4193/rhin22.316
BibTeX
@article{Thorstensen2023,
author = {Thorstensen, W M and Rystad Oie, M and Sue-Chu, M and Karmhus Steinsvag, S and Helvik, A-S},
title = {Peak nasal inspiratory flow in chronic obstructive pulmonary disease},
journal = {Rhinology Journal},
year = {2023},
volume = {0},
number = {0},
pages = {0--0},
doi = {10.4193/rhin22.316}
}
EUVIMED